Transgenic expression of antimicrobial peptide D2A21 confers resistance to diseases incited by Pseudomonas syringae pv. tabaci and Xanthomonas citri, but not Candidatus Liberibacter asiaticus.

MLA

Hao, Guixia, et al. “Transgenic Expression of Antimicrobial Peptide D2A21 Confers Resistance to Diseases Incited by Pseudomonas Syringae Pv. Tabaci and Xanthomonas Citri, but Not Candidatus Liberibacter Asiaticus.” PLoS ONE, vol. 12, no. 10, Oct. 2017, pp. 1–17. EBSCOhost, https://doi.org/10.1371/journal.pone.0186810.

APA

Hao, G., Zhang, S., & Stover, E. (2017). Transgenic expression of antimicrobial peptide D2A21 confers resistance to diseases incited by Pseudomonas syringae pv. tabaci and Xanthomonas citri, but not Candidatus Liberibacter asiaticus. PLoS ONE, 12(10), 1–17. https://doi.org/10.1371/journal.pone.0186810

Chicago

Hao, Guixia, Shujian Zhang, and Ed Stover. 2017. “Transgenic Expression of Antimicrobial Peptide D2A21 Confers Resistance to Diseases Incited by Pseudomonas Syringae Pv. Tabaci and Xanthomonas Citri, but Not Candidatus Liberibacter Asiaticus.” PLoS ONE 12 (10): 1–17. doi:10.1371/journal.pone.0186810.